This approach has not been formally studied in large trials for Retatrutide specifically, but the dose-response data suggests it is viable
External resources Phase 2 clinical trial: Once-weekly cagrilintide for weight management (The Lancet) REDEFINE 1: Coadministered cagrilintide and semaglutide (NEJM) Systematic review: Efficacy and safety of cagrilintide alone and in combination (PMC) For researchers serious about navigating cagrilintide protocols safely, SeekPeptides provides comprehensive, evidence-based guides, dosing tools, and a community of experienced researchers who have worked through these exact questions
In weight management trials, approximately 44% of participants experienced nausea, but 98% of these cases were mild to moderate
Journal of the American Academy of Child & Adolescent Psychiatry
How does genetic testing help with semaglutide dosing decisions at PlexusDx
During the luteal phase of the menstrual cycle, progesterone effects on the autonomic nervous system, and the net result is an increase in GET [25]